KKR, a global investment firm, announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (Frontier), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in…